Emmessar Biotech & Nutrition Ltd

Emmessar Biotech has experienced significant fluctuations in financial performance, with net sales and operating income peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25, while operating profit turned negative and total assets and liabilities increased. The company has shown a consistent zero balance in cash and cash equivalents, indicating poor cash flow.

As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is at 31.05, with a slight increase of 0.16%. Despite a recent uptick and increased investor interest, the stock has underperformed significantly year-to-date, declining 32.94% compared to the broader market's gains.

Emmessar Biotech will announce its results on 12 November 2025.

As of 30-Oct, Emmessar Biotech & Nutrition Ltd's stock price is Rs 29.56, down 4.65%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with a significant drop in delivery volume and a year-to-date decline of 36.16%.

As of 10-Oct, Emmessar Biotech & Nutrition Ltd's stock price is at 31.50, down 1.19% and underperforming with a year-to-date decline of 31.97%. Despite a recent positive return of 14.55% over the past month, it lags behind the benchmark Sensex, which has gained 5.58% year-to-date.

As of 29-Sep, Emmessar Biotech & Nutrition Ltd's stock is priced at Rs 32.20, down 5.15% and has declined 9.07% over three days, indicating significant selling pressure and decreased investor interest. The stock's year-to-date decline of 30.45% contrasts with its previous strong performance, reflecting a challenging environment.

As of 24-Sep, Emmessar Biotech & Nutrition Ltd's stock price is at 35.49, showing a slight increase today but has underperformed in the short term with a 1-week return of -8.72% and a year-to-date decline of -23.35%. Despite recent gains, the overall trend remains weak compared to the broader market, indicating challenges in investor sentiment.

As of 23-Sep, Emmessar Biotech & Nutrition Ltd is priced at 35.30, down 1.29%, and has underperformed significantly with a year-to-date decline of 23.76% compared to a 5.07% increase in the benchmark index. Despite a recent short-term gain, the stock's declining investor participation and overall negative outlook indicate ongoing challenges.

As of 22-Sep, Emmessar Biotech & Nutrition Ltd's stock price is Rs 35.75, down 3.59% and has fallen 9.26% over the last two days. Despite a recent short-term gain of 32.41%, the stock's year-to-date return is -22.79%, indicating volatility and declining investor confidence.

As of 19-Sep, Emmessar Biotech & Nutrition Ltd is priced at Rs 37.08, down 5.89% today, marking a trend reversal after four days of gains. Despite recent strong performance over the past week and month, the stock has underperformed against the Sensex and is down 19.91% year-to-date.

As of 18-Sep, Emmessar Biotech & Nutrition Ltd is currently priced at 39.40, reflecting a recent strong performance with a 49.19% gain over four days, despite a year-to-date decline of 14.90%. The stock is trading above all key moving averages, indicating positive momentum and increased investor interest.

As of 17-Sep, Emmessar Biotech & Nutrition Ltd's stock price has risen to Rs 38.88, reflecting a 20% increase and strong performance over the past week with a 41.38% return. The stock is trading above all key moving averages, indicating a positive trend and heightened investor interest.

As of 15-Sep, Emmessar Biotech & Nutrition Ltd is priced at Rs 27.00, showing a recent increase but still trading below key moving averages and near its 52-week low. Despite a rise in investor participation, the stock has underperformed compared to the Sensex, with significant declines year-to-date.

As of 12-September, Emmessar Biotech & Nutrition Ltd's stock price is Rs 26.41, down 3.58%, and has underperformed significantly, trading below key moving averages and nearing its 52-week low. The stock has seen a year-to-date decline of 42.96%, with weak investor sentiment and declining participation, contrasting sharply with the benchmark Sensex's recent gains.

As of 11-Sep, Emmessar Biotech & Nutrition Ltd's stock price is at 27.39, down 0.4%. Despite a 2.97% increase over the past week, the stock has significantly underperformed the Sensex and shows a year-to-date decline of 40.84%.

As of 10-Sep, Emmessar Biotech & Nutrition Ltd's stock price is declining at 27.50, down 0.43%, and has underperformed its sector and the broader market significantly. The stock has seen a 40.60% year-to-date decline and a 32.10% drop over the past year, with reduced investor participation contributing to its current negative trend.

As of 09-Sep, Emmessar Biotech & Nutrition Ltd's stock price has increased to 27.62, reflecting a 1.4% gain today, but it has a year-to-date decline of 40.35%. Despite recent short-term gains, long-term performance remains weak, and decreasing investor participation suggests caution.

As of 08-Sep, Emmessar Biotech & Nutrition Ltd's stock price has increased to 27.24, up 2.41% today, but it has declined 4.86% over the past month and 41.17% year-to-date. Despite today's positive movement, the stock has underperformed the market overall, leading to cautious investor sentiment.

As of 04-September, Emmessar Biotech & Nutrition Ltd's stock price is Rs 26.60, down 0.34%, and has declined 2.35% over the last three days. The stock is underperforming compared to the market, with a year-to-date drop of 42.55% and is close to its 52-week low, indicating negative investor sentiment.